Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Vita 34 AG (V3VGn)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.860 -0.080    -1.62%
03:20:47 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  DE000A0BL849 
WKN:  A0BL84
  • Volume: 1,042
  • Bid/Ask: 4.640 / 4.860
  • Day's Range: 4.800 - 4.860
Vita 34 AG 4.860 -0.080 -1.62%

Vita 34 AG Company Profile

 
Get an in-depth profile of Vita 34 AG, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Providers & Services
SectorHealthcare
Employees

775

Equity Type

ORD

VITA 34 AG engages in the collection, processing, and cryopreservation of stem cells from umbilical cord blood and tissue in Germany, Poland, Portugal, and internationally. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces viral vectors and CAR-T cells. The company manufactures advanced therapy medicinal products for third parties. In addition, it offers a range of products for long-term storage of biological material obtained at birth, as well as placental blood or umbilical cord tissue or placenta tissue. Further, the company provides sperm banking services for freezing sperm; adipose tissue banking services as a source of mesenchymal stem cells and stromal vascular fraction; medical consultations and non-diagnostic ultrasound examination services; and other contract manufacturing services for classical transplantations or cell and gene therapies. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.

Contact Information

Address Deutscher Platz 5a
Leipzig, 04103
Germany
Phone 49 341 48792 40
Fax 49 341 48792 39

Top Executives

Name Age Since Title
Robert Iannone - - Member of Scientific & Medical Advisory Board
Ronald J. Wapner - - Member of Scientific & Medical Advisory Board
Carlo Maria Croce - - Member of Scientific & Medical Advisory Board
A. Bader - - Member of Scientific & Medical Advisory Board
Jack Goldberg - - Member of Scientific & Medical Advisory Board
Zbigniew Roger Mrowiec - - Member of Scientific & Medical Advisory Board
Isadore G. Ances - - Member of Scientific & Medical Advisory Board
W. Holzgreve - - Member of Scientific & Medical Advisory Board
E. Wunder - - Member of Scientific & Medical Advisory Board
Alexander Granderath - 2021 Chairman of Supervisory Board
Frank Köhler 58 2017 Independent Member of the Supervisory Board
Florian Martin Schuhbauer 47 2020 Deputy Chairman of the Supervisory Board
Konrad Miterski - 2022 Member of the Supervisory Board
Ursula Schutze-Kreilkamp - 2022 Member of the Supervisory Board
Paul Owsianowski - 2022 Member of the Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

V3VGn Comments

Write your thoughts about Vita 34 AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email